
Opinion|Videos|April 23, 2024
Navigating Insurance Coverage for Prescription Digital Therapeutics
Mahsa Salsabili, PharmD, PhD, addresses the challenges surrounding insurance approval and the limited announcements regarding coverage for prescription digital therapeutics, while exploring various reimbursement models, such as value-based contracts and outcome-based rebates.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Socioeconomic, age disparities found in retina practice patient dismissals | ASRS 2026
2
Vabysmo cuts injections while preserving vision in DME patients | ASRS 2026
3
Loss of copay assistance linked to worse outcomes in retina patients | ASRS 2026
4
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
5

























